Literature DB >> 20623298

Myasthenia gravis: a changing pattern of incidence.

I Casetta1, E Groppo, R De Gennaro, E Cesnik, L Piccolo, S Volpato, E Granieri.   

Abstract

The annual incidence of myasthenia gravis (MG) ranges from 3 to 30 per 1,000,000 people. Since the mid-1980s, an increasing incidence has been reported, mainly due to late-onset MG. Whether the increase was due to population aging, improved diagnosis and case collection, or a true excess of incidence cases is still under debate. We used a complete enumeration approach by reviewing all possible sources of case collection in the province of Ferrara, Italy, to estimate the MG incidence and its temporal trend over the study period (1985-2007). The mean annual age-adjusted incidence of MG was 18 per 1,000,000, without any significant temporal trend. The incidence rates in the period 1985-1990 were 14 both for early and late-onset MG. Thereafter, a significant increase in incidence of late-onset MG (p < 0.05), and a decrease in early onset MG were detected (p < 0.01). These findings were related to nonthymoma MG. The median age at onset of the disease steadily increased over time. A changing pattern of MG incidence with an increase in frequency of late-onset and a decrease of early onset MG was found in the last years, giving a significant shift to older age at onset of the disease. Unknown environmental factors may have driven this change in MG epidemiology.

Entities:  

Mesh:

Year:  2010        PMID: 20623298     DOI: 10.1007/s00415-010-5651-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

1.  Myasthenia gravis: a higher than expected incidence in the elderly.

Authors:  J M Aragonès; I Bolíbar; X Bonfill; E Bufill; A Mummany; F Alonso; I Illa
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

2.  Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.

Authors:  Finn E Somnier
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

3.  Incidence of myasthenia gravis in the Emilia-Romagna region: a prospective multicenter study. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology.

Authors: 
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

Review 4.  The incidence of myasthenia gravis: a systematic literature review.

Authors:  Anita McGrogan; Samantha Sneddon; Corinne S de Vries
Journal:  Neuroepidemiology       Date:  2010-02-02       Impact factor: 3.282

5.  Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis.

Authors:  D A Compston; A Vincent; J Newsom-Davis; J R Batchelor
Journal:  Brain       Date:  1980-09       Impact factor: 13.501

6.  Epidemiology of seropositive myasthenia gravis in Greece.

Authors:  K Poulas; E Tsibri; A Kokla; D Papanastasiou; T Tsouloufis; M Marinou; P Tsantili; T Papapetropoulos; S J Tzartos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

7.  Seropositive myasthenia gravis: a nationwide epidemiologic study.

Authors:  Anne Taraldsen Heldal; Jone Furlund Owe; Nils Erik Gilhus; Fredrik Romi
Journal:  Neurology       Date:  2009-07-14       Impact factor: 9.910

8.  Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan.

Authors:  N Matsui; S Nakane; Y Nakagawa; K Kondo; T Mitsui; T Matsumoto; K Arisawa; R Kaji
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-10       Impact factor: 10.154

9.  Evidence of underdiagnosis of myasthenia gravis in older people.

Authors:  A Vincent; L Clover; C Buckley; J Grimley Evans; P M Rothwell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

10.  Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey.

Authors:  F E Somnier; N Keiding; O B Paulson
Journal:  Arch Neurol       Date:  1991-07
View more
  18 in total

1.  Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.

Authors:  Roberto Massa; Giulia Greco; Manuela Testi; Emanuele Rastelli; Chiara Terracciano; Erica Frezza; Matteo Garibaldi; Girolama A Marfia; Franco Locatelli; Nicola B Mercuri; Eugenio Pompeo; Giovanni Antonini; Marco Andreani
Journal:  J Neurol       Date:  2019-02-11       Impact factor: 4.849

2.  Unusual case of recurrent falls: myasthenia gravis in an elderly patient.

Authors:  Tareef Alaama; Pari Basharat; Michael W Nicolle
Journal:  Can Fam Physician       Date:  2012-11       Impact factor: 3.275

3.  Estimation of incidence, prevalence, and age-at-diagnosis of myasthenia gravis among adults by hospital discharge records.

Authors:  Anett Foldvari; Nora Kovacs; Valeria Sipos; Gabriella Merth; Ferenc Vincze; Maria Szucs; Janos Sandor
Journal:  Wien Klin Wochenschr       Date:  2015-05-20       Impact factor: 1.704

4.  Causes, background, and characteristics of binocular diplopia in the elderly.

Authors:  Manami Kawai; Toshiaki Goseki; Hitoshi Ishikawa; Miki Hoshina; Nobuyuki Shoji
Journal:  Jpn J Ophthalmol       Date:  2018-08-12       Impact factor: 2.447

5.  Incidence of epilepsy in Ferrara, Italy.

Authors:  Edward Cesnik; Francesco Pedelini; Raffaella Faggioli; Vincenza Cinzia Monetti; Enrico Granieri; Ilaria Casetta
Journal:  Neurol Sci       Date:  2013-04-26       Impact factor: 3.307

6.  Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society.

Authors:  Hakan Cetin; Gerhard Fülöp; Heidemarie Zach; Eduard Auff; Fritz Zimprich
Journal:  Wien Klin Wochenschr       Date:  2012-11-06       Impact factor: 1.704

7.  Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia.

Authors:  Agnes van Sonderen; Paul W Wirtz; Jan J G M Verschuuren; Maarten J Titulaer
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

8.  Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009.

Authors:  Katherine E Brick; Chad H Weaver; Christine M Lohse; Mark R Pittelkow; Julia S Lehman; Michael J Camilleri; Mustafa Al-Hashimi; Carilyn N Wieland
Journal:  J Am Acad Dermatol       Date:  2014-04-03       Impact factor: 11.527

9.  Incidence and Prevalence of Myasthenia Gravis in Korea: A Population-Based Study Using the National Health Insurance Claims Database.

Authors:  Su Yeon Park; Jin Yong Lee; Nam Gu Lim; Yoon Ho Hong
Journal:  J Clin Neurol       Date:  2016-05-10       Impact factor: 3.077

10.  Association of HLA-DQB1∗05:02 and DRB1∗16 Alleles with Late-Onset, Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis.

Authors:  Manuela Testi; Chiara Terracciano; Annalisa Guagnano; Giuseppe Testa; Girolama A Marfia; Eugenio Pompeo; Marco Andreani; Roberto Massa
Journal:  Autoimmune Dis       Date:  2012-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.